LivaNova (LIVN) Profit After Tax Growth (1y) (2015 - 2026)
LivaNova (LIVN) Profit After Tax Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn | 18.66% |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn | 13.84% |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn | -27.98% |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 14.60% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 71.04% |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn | 12.92% |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn | 299.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 299.72% |
| Mar 31, 2026 | 106.81% |
| Dec 31, 2025 | -44.70% |
| Sep 30, 2025 | -18.72% |
| Jun 30, 2025 | 66.30% |
| Mar 31, 2025 | -680.40% |
| Dec 31, 2024 | 242.07% |
| Sep 30, 2024 | 550.30% |
| Jun 30, 2024 | 1,314.11% |
| Mar 31, 2024 | -669.10% |
| Dec 31, 2023 | 883.68% |
| Sep 30, 2023 | 93.18% |
| Jun 30, 2023 | -92.98% |
| Mar 31, 2023 | 146.24% |
| Dec 31, 2022 | 132.40% |
| Sep 30, 2022 | -147.09% |
| Jun 30, 2022 | 129.11% |
| Mar 31, 2022 | 109.73% |
| Dec 31, 2021 | 98.18% |
| Sep 30, 2021 | -193.26% |